Crescita Therapeutics Email Format

Pharmaceutical ManufacturingOntario, Canada51-200 Employees

Crescita Therapeutics is a publicly traded Canadian pharmaceutical company based in Mississauga, Ontario, with a workforce ranging between 51 and 200 employees. It focuses on dermatology, offering a portfolio of non-prescription skincare products for the treatment and care of skin conditions and symptoms, as well as prescription drug products for pain treatment. The company owns proprietary transdermal delivery platforms, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel, designed to facilitate the delivery of active drugs into or through the skin. It has pursued development efforts beyond traditional dermatology, including formulations for topical cannabis and hemp products using its delivery technologies and collaborations to enhance a dermatology portfolio with these platforms. Crescita trades on the TSX under the ticker CTX and, in June 2024, completed an asset acquisition for a total cash consideration of $0.9 million.

Sign up for free to view info

Company overview Employee directory